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ABSTRACT The ability to change cell morphology is an advantageous characteristic adopted by multiple pathogenic bacteria in
order to evade host immune detection and assault during infection. Uropathogenic Escherichia coli (UPEC) exhibits such cellu-
lar dynamics and has been shown to transition through a series of distinct morphological phenotypes during a urinary tract in-
fection. Here, we report the first systematic spatio-temporal gene expression analysis of the UPEC transition through these phe-
notypes by using a flow chamber-based in vitro infection model that simulates conditions in the bladder. This analysis revealed a
novel association between the cell division gene damX and reversible UPEC filamentation. We demonstrate a lack of reversible
bacterial filamentation in a damX deletion mutant in vitro and absence of a filamentous response by this mutant in a murine
model of cystitis. While deletion of damX abrogated UPEC filamentation and secondary surface colonization in tissue culture
and in mouse infections, transient overexpression of damX resulted in reversible UPEC filamentation. In this study, we identify a
hitherto-unknown damX-mediated mechanism underlying UPECmorphotypical switching. Murine infection studies showed
that DamX is essential for establishment of a robust urinary tract infection, thus emphasizing its role as a mediator of virulence.
Our study demonstrates the value of an in vitromethodology, in which uroepithelium infection is closely simulated, when un-
dertaking targeted investigations that are challenging to perform in animal infectionmodels.
IMPORTANCE Urinary tract infections (UTIs) are most often caused by uropathogenic Escherichia coli (UPEC) and account for a
considerable health care burden. UPEC exhibits a dynamic lifestyle in the course of infection, in which the bacterium transiently
adopts alternative morphologies ranging from rod shaped to coccoid and filamentous, rendering it better at immune evasion
and host epithelium adhesion. This penchant for morphotype switching might in large measure account for UPEC’s success as a
pathogen. In aiming to uncover genes underlying the phenomenon of UPECmorphotype switching, this study identifies damX, a
cell division gene, as a mediator of reversible filamentation during UTI. DamX-mediated filamentation represents an additional
pathway for bacterial cell shape control, an alternative to SulA-mediated FtsZ sequestration during E. coli uropathogenesis, and
hence represents a potential target for combating UTI.
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The success of a bacterial pathogen depends on its ability tosense its environment and adapt suitably to ensure the best
odds of survival. One such adaptation that bestows a selective
advantage on the pathogen is its potential for morphological plas-
ticity (1–3). Bacteria have been known to adopt a filamentous
morphology when subjected to stresses such as starvation (4), pH
change (5), low water activity (6), and exposure to antimicrobial
agents (7).
Uropathogenic Escherichia coli (UPEC) has evolved a charac-
teristic lifestyle within the host that enables efficient immune eva-
sion and renders it a successful pathogen. UPEC is the most com-
mon cause of urinary tract infections (UTIs) (8), and these
bacteria have been observed to undergo morphological differen-
tiation during infection in mice (9) and humans (10). In the
course of an acute UTI, the normally rod-shaped UPEC adheres to
and invades the superficial cells of the bladder urothelium. Invad-
ing UPEC replicates within intracellular bacterial communities
(IBCs), consisting mainly of coccoid bacteria (11). Eventually, the
intracellular bacterial burden leads to host cell death, at which
point UPEC bacteria leave the host cell in the form of motile rods
as well as highly filamentous bacteria. The UPEC filaments re-
leased into the extracellular milieu possess the ability to revert to
the original rod-shaped morphology with the potential to reiniti-
ate a new cycle of infection. Although knowledge of the UPEC
infection cycle is derived mainly from murine models of cystitis,
IBCs and UPEC filaments have been detected in urine samples
from humans with acute UTI (10). The ability to revert to normal
rod-shaped morphology is as critical as the ability to form fila-
ments, not just in the case of bacteria like UPEC that adopt fila-
mentation as a virulence strategy but also in cases where filamen-
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tation is a result of sublethal stress (1). Studies have shown that
filamentation of pathogenic bacteria is likely either part of a strat-
egy that helps the pathogen evade the host innate immune re-
sponse (9, 12) or a stress coping mechanism within a hostile host
(13).
The phenomenon of bacterial filamentation is, in essence, a
consequence of stalled cell division in the bacterial cell. Cell divi-
sion, a complex process involving ~30 essential and nonessential
genes (14), comprises a sequence of events that commences with
the assembly of a membrane-tethered cytoplasmic proto-ring
(15). The proto-ring comprises FtsZ, FtsA, and ZipA, which rep-
resent the earliest recruits to the septal plane (16), followed by
other proteins that build on the proto-ring after a considerable
time lag (17). The final step in cell division involves cell wall pep-
tidoglycan remodeling, i.e., degradation of preexisting pepti-
doglycan and synthesis of septal peptidoglycan (18), which ulti-
mately results in cell wall invagination and the formation of two
daughter cells.
While some studies have aimed at identifying genes involved in
bacterial filamentation (13, 19–21), this study is the first to sys-
tematically analyze the UPEC gene expression profiles at each in-
dividual phase of its pathogenesis, with the aim of identifying
genes that are critical to its morphological differentiation. Using
microarray technology and a previously described (22) flow
chamber-based bladder cell infection model, this study not only
reaffirms recent reports regarding the importance of a contact
surface and fluid flow in UPEC filamentation (23) but also iden-
tifies DamX as a key factor that controls reversible switching be-
tween normal rod-shaped and filamentous morphology during
infection. While previous studies have linked UPEC filamentation
with the SOS response and SulA (9, 12, 20), our present study
identifies transient DamX overproduction as a key inducer of fila-
mentation during this cycle. Based on the currently available data,
we propose that both mechanisms act in concert to create the
extensive filamentation observed in vivo but that they are triggered
by different mechanisms: the DamX filamentation triggered as a
response to the shift from intracellular growth to urine- and liquid
shear-exposed surface growth and the SOS filamentation trig-
gered by immune cell attack (12).
RESULTS
Expression analysis revealed differential UPEC transcription
profiles during in vitro infection. The infection cycle of the
UPEC strain UTI89, originally isolated from a case of cystitis (24),
has been well characterized since early reports more than a decade
ago of UPEC intracellular behavior during infection (25, 26).
Characterization of the genes responsible for progression of the
UPEC infection cycle has been limited by the obvious challenges
of low bacterial yields from in vivo infection models and the in-
ability to recapitulate the cycle in vitro. We recently established an
in vitro infection model capable of supporting the morphological
changes inherent to progression of the UPEC infection cycle (22).
Working on the assumption that the morphological transitions
observed in our in vitro model reflect many of the characteristics
of an in vivo infection, we explored the unique opportunity of-
fered by this model to harvest and analyze bacteria from distinct
phases of infection. Systematic transcriptional profiling of UTI89
obtained from the intracellular, filamentous, and filament reversal
(here referred to as reversal) phases was performed using microar-
ray technology (illustrated in Fig. S1a in the supplemental mate-
rial). A custom-designed UTI89-specific array was used to identify
both annotated and unannotated transcripts covering the entire
UTI89 genome (accession number NC_007946.1) as well as that
of pUTI89 (accession number NC_007941.1). Bacterial cells har-
vested from the flow chamber apparatus representing the filamen-
tous and reversal phases were isolated from three independent
flow chamber experiments and used for hybridization as biologi-
cal triplicates on the UTI89 array. In order to ascertain the fraction
of the sample that was truly filamentous, UTI89 was harvested
after growth under two conditions—a reference condition that
resulted in rod-shaped UTI89 cells grown in LB culture and a
filamentous condition from within the flow chambers during the
filamentous phase of infection—and analyzed using flow cytom-
etry. Gating was performed on the culture-grown, normal rod-
shaped bacteria, resulting in the populations “P1” and “not P1,”
such that rod-shaped bacteria were represented in the former and
filaments were represented in the latter populations. Examination
of the two populations under the two conditions revealed that
~80% of the flow chamber sample was filamentous, with an
FSC-A median (forward scatter area, a measure of cell length) of
2,385, compared to an FSC-A median of ~30 in the nonfilamen-
tous rod-shaped P1 population (Fig. 1a). Since the filamentous
phase also contains a small fraction of rod-shaped bacteria, it is
possible that expression levels in this phase are underestimated.
Due to the relatively low yield of bacterial mRNA from the
intracellular phase, samples were pooled from four parallel flow
chambers in three independent experiments to yield biological
triplicates. In order to obtain reference conditions that were un-
biased toward a particular growth environment, bacteria were cul-
tured to stationary phase in nutrient-rich Luria-Bertani (LB)
broth representing the growth medium at the time of infection, as
well as sterile human urine with a urine specific gravity (USG; the
density) of1.025, representing the flow medium during in vitro
infection. The choices of growth phase and culture medium for
the reference condition were admittedly challenging, since the
UPEC growth phase and nutrient sources are likely subject to
frequent changes during intra- and extracellular growth in the
flow chamber model.
Gene transcripts from intracellular, filamentous, and reversal
phases were filtered on the basis of theP value and log2 fold change
in expression, individually, compared to the reference conditions,
urine and LB broth. Among the transcripts that crossed the fold
change and P value thresholds, those that demonstrated disparate
expression trends (up- or downregulated) compared to LB and
urine cultures were excluded from further analysis. These tran-
scripts would more likely represent a response to the particular
growth environment (LB/urine). Only gene transcripts from each
of the three phases that showed consistent trends of differential
expression, irrespective of the reference used (LB/urine), were
considered further.
A total of 351 transcripts in intracellular phase, 845 in filamen-
tous phase, and 447 in reversal phase were found to display a
statistically significant difference in t test results, i.e., P values of
0.05 and fold changes of2 log2 compared to the urine cultured
reference condition. Among the significant differentially ex-
pressed transcripts, 27% of those in the intracellular phase, 33% in
the reversal phase, and 75% in the filamentous phase were found
to be uniquely differentially expressed during each particular
phase of infection. Examination of the significant transcripts re-
vealed that the expression profiles during the intracellular and
Khandige et al.
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reversal phase were more comparable, while the expression profile
during the filamentous phase showed not only a deviation from
the other two phases but also a state of increased transcriptional
activity (reflected in the higher number of upregulated genes that
passed the statistical threshold). Gene ontology distribution of the
significant transcripts showed an enrichment of genes involved in
metabolic processes and cell division in the filamentous phase of
infection (see Fig. S1c in the supplemental material).
DeletionofdamX resulted inabrogationof thefilamentation
phenotype in vitro. The observation that cell division was among
the ontologies differentially expressed in the filamentous phase of
UTI89 (see Fig. S1c in the supplemental material) was not unex-
pected, since bacterial filamentation essentially results from an
absence of cytokinesis. The array data revealed a cluster of genes
upregulated in filaments that included several cell division genes
involved in septal ring formation, like zapB (5.2-fold log2 change),
ftsZ (6.6-fold log2), ftsA (3.2-fold log2), and cedA (8.4-fold log2),
all of which were correspondingly 2- to 6-fold log2 downregulated
in the preceding intracellular and subsequent reversal phases (see
Fig. S1b). The observation that genes encoding proto-ring com-
ponents ftsZ, ftsA, and zipA that were upregulated in filaments
indicated that a halt in cell division probably occurred down-
stream of proto-ring assembly. In addition to some essential and
nonessential division genes, two genes belonging to the SPOR do-
main class of proteins (damX and rlpA) were found to be signifi-
cantly upregulated in filaments (6-fold log2 and 4.2-fold log2, re-
spectively). Conversely, genes encoding other known SPOR
domain proteins, FtsN and DedD, were not significantly upregu-
lated during filamentation. Real-time PCR was performed to val-
idate expression levels of several of the cell division genes; data are
presented as expression levels in UTI89 filaments relative to ex-
pression in a stationary UTI89 urine culture (Fig. 1b).
Based on our findings and previous studies linking cell division
genes to a filamentous morphology, sulA (9, 27), slmA (28), zapB
(29), cedA (30), and damX (31) were chosen for further explora-
tion in the context of UPEC filamentation. Individual deletion
strains for the genes were constructed in UTI89 in order to evalu-
ate their influence on filamentation in the flow chamber infection
model. Strains UTI89cedA, UTI89zapB, UTI89sulA,
UTI89damX, and UTI89slmA were all found to demonstrate
growth rates comparable to UTI89 wild type when cultured in LB
broth and urine (see Fig. S2a in the supplemental material), con-
firming viability of the respective deletion strains. All five deletion
strains were subsequently tested along with the UTI89 wild type
for their ability to form filaments and secondary surface coloniza-
tion, i.e., phenotypes originating from an intracellular reservoir
post-gentamicin treatment, in the flow chamber infection model
(Fig. 2a). We observed that while UTI89cedA, UTI89zapB,
UTI89sulA, and UTI89slmA mutant strains behaved similarly
to wild-type UTI89, demonstrating both secondary surface colo-
nization and concurrent filament formation, the UTI89damX
strain was unable to produce both phenotypes.
In order to investigate whether the lack of filamentation was
merely due to an inability of strain UTI89damX to adhere to and
invade the bladder epithelial cell line, UTI89damX mutant cells
were tested in a stationary infection setup performed using the
bladder epithelial cell line PD07i in multiwell plates. These results
showed that the UTI89damX mutant efficiency equaled that of
the wild type in early bladder cell adhesion and invasion in short-
term in vitro infection (see Fig. S2b and c in the supplemental
FIG1 Expression of cell division genes in UTI89 filaments. (a) The fraction of filamentous bacteria in the population was ascertained by flow cytometry analysis.
The scatterplot was gated based on the population of normal rod-shaped bacteria, with gate P1 representing normal rod-shaped bacteria from strain UTI89 (blue)
and gate “notP1” representing UTI89 filaments (pink), with forward scatter and side scatter on the x and y axes, respectively. (b) The expression levels of cell
division genes that were found to be differentially expressed between filaments and the urine reference condition were validated by real-time PCR. The graph
represents mean expression values of UTI89 in the filament phase relative to expression levels under the reference condition of strain UTI89 cultured in urine,
expressed as the fold change on a log2 scale.
DamX Controls Reversible UPEC Filamentation
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material). Additionally, to assess possible intracellular growth de-
fects in the UTI89damX mutant, we performed a plasmid reten-
tion assay using a temperature-sensitive low-copy-number plas-
mid, pKD46 (32). The percentage of plasmid-retaining bacterial
cells at 24 h postinfection (hpi) was found to be on average around
70% in strain UTI89/pKD46 and 72% in strain UTI89damX/
pKD46, demonstrating that both strains underwent similar num-
bers of intracellular division events (see Fig. S2d) and indicating
that damX deletion does not lead to intracellular growth attenua-
tion. We further plotted a standard curve of the percent retention
of the pKD46 plasmid along the growth curve, as a function of
time, to estimate the average number of intracellular generations.
Both the UTI89 and UTI89damX strains grew to an average of 4
to 5 generations intracellularly (based on the doubling times de-
picted in Fig. S2a), as depicted in Fig. S2e.
Recent studies have reported that damX, first identified as
urf74.3 by Lyngstadaas et al. (31), encodes a SPOR domain-
containing protein that is recruited to the septum during cell di-
vision (33, 34). SPOR domains are found in many bacterial pro-
teins and are involved in binding to septal peptidoglycan (35–37).
Overproduction of DamX has been reported to result in a failure
in cell division and a filamentous morphology, while deletion of
the damX gene has been associated with bile sensitivity (38) with-
out a discernible impact on cell morphology (34). damX is part of
a functionally diverse operon comprised of aroBK, damX, dam,
rpe, gph, and trpS. Some previous studies suggested that polarity
effects of damX deletion on the downstream dam gene, which
encodes the Dam DNA methylase, could account for the pheno-
types associated with damX deletion, due to a likely 70 damp1
promoter within the damX open reading frame (39–41). Analysis
of dam, aroBK, and damX expression levels in the UTI89damX
mutant relative to the UTI89 wild type revealed no significant
effect of damX deletion on dam expression (see Fig. S3a in the
supplemental material). In order to confirm with certainty the
absence of any polarity issues, we constructed and tested a more
subtle deletion mutant, UTI89damX*, in which the damp1 pro-
moter was left intact. The UTI89damX* deletion strain repli-
cated the filamentation defect displayed by strain UTI89damX
during the flow chamber-based infection experiments (see
Fig. S3b). This finding indicated that the lack of filamentation
observed in strain UTI89damX was more likely attributable di-
rectly to the deletion of damX rather than secondary dam-
mediated effects.
The UTI89damXmutant is unable to form filaments in an
in vivomousemodel. In order to validate our findings from the in
vitro flow chamber model and assess the role of DamX as a medi-
ator of UPEC filamentation within a complex in vivo environ-
ment, a mouse cystitis model based on the strain C3H/HeN was
chosen for further investigation. C3H/HeN mice are known to be
fully immunocompetent, with a wild-type tlr-4 gene and a func-
tional PMN (polymorphonuclear leukocyte) response. This
mouse strain has been reported to support a robust UPEC patho-
genesis cycle in several previous studies (25).
Female C3H/HeN mice were separately inoculated via trans-
urethral catheterization with strain UTI89/pMAN01 or
UTI89damX/pMAN01 subcultured over two rounds of static
growth at 37°C in LB medium. The strains were transformed with
the pMAN01 plasmid to ensure constitutive expression of gfp,
enabling easy microscopic examination of the bacteria. The
mouse bladders at 12 and 18 hpi as well as urine collected imme-
diately prior to tissue harvest at 12 h were subjected to micro-
scopic examination for bacterial filaments, exfoliated cells, and
IBCs. Alongside this, CFU counts were estimated in bladder ho-
mogenates at 18 h, 48 h, and 14 days postinfection. At the 12-h
time point, several IBCs were observed in bladders infected with
strain UTI89damX, although they appeared to be fewer in num-
ber than in wild-type-infected bladders (Fig. 3a and b). Inspec-
tions of urine specimens at this time point revealed relatively high
numbers of exfoliated cells containing IBCs also from the mutant
strain infections (Fig. 3h), showing that IBCs are formed by strain
UTI89damX, but they are cleared more rapidly than the wild-
type strain.
At 18 hpi, IBCs were largely cleared from bladders infected
with strain UTI89damX, whereas IBCs were still present in wild-
type-infected bladders (Fig. 3c and e). The wild-type strain,
UTI89wt, exhibited abundant filamentation (Fig. 3d), whereas no
filaments were detected in the bladders infected with strain
UTI89damX. Mutant UTI89damX cells were, however, few
and far apart on the bladder lumen wall, making it difficult, based
on these inspections alone, to conclude on a possible filamenta-
tion defect. By pooling urine samples from strain UTI89damX-
infected mice, much higher numbers (thousands) of bacteria
could be analyzed. Strain UTI89damX in these samples were all
found to be normal rod shaped or only slightly elongated (Fig. 3i),
which was in stark contrast to the highly filamentous response
present in the urine from UTI89wt strain infections (Fig. 3g).
Regarding overall bacterial numbers in the bladders, CFU
counts were approximately 2.5 orders of magnitude lower for
strain UTI89damX/pMAN01 than for the UTI89/pMAN01
strain at 18 hpi (Fig. 4), thus indicating a significant defect in
FIG 2 Strain UTI89damX was unable to demonstrate secondary infection or filamentation on urine exposure. Flow chamber-based infection of the PD07i
bladder cell line was carried out with strains UTI89wt, UTI89slmA, UTI89zapB, UTI89cedA, UTI89sulA, and UTI89damX. Panels in the top row
represent secondary infection and biofilm formation (cloudy appearance) on exposure to concentrated urine, and the bottom row depicts bacteria flushed out
of the flow chambers after 22 h of concentrated urine exposure. Scale bars, 20 m.
Khandige et al.
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progression of infection beyond the initial intracellular infection
cycle.
CFU counts measured at 48 h and 14 days postinfection re-
vealed a severely diminished capacity for persistence of strain
UTI89damX/pMAN01 during bladder infection. The CFU de-
tection limit was set at 50 bacteria per bladder, implying that a
count of 50 bacteria was equivalent to complete clearance of
infection. A deletion of damX resulted in clearance of the infection
at 48 hpi, whereas the UTI89/pMAN01 strain presented high CFU
counts in the mouse bladders even at 14 days postinfection
(Fig. 4).
Previously, Justice et al. (9) proposed a sulA-driven SOS-
mediated response as a mechanism underlying UPEC filamenta-
tion during the uropathogenic cycle. While our in vitro infections
failed to show a correlation between sulA and UPEC filamentation
(Fig. 2), this could have been due to the absence of immune cell
attack in this model, which has been hypothesized to underlie the
SOS-triggered filamentation (9). To be able to better investigate
an in vivo sulA-filamentation association that perhaps could not
be observed in the in vitro flow chamber model, we performed
infections of the C3H/HeN mouse strain with strain UTI89sulA/
pMAN01. A visual examination of splayed bladders 18 hpi re-
vealed a scenario akin to UTI89damX strain infection, with very
few or no IBCs and no detectable filaments (see Fig. S4a in the
supplemental material). Notwithstanding the overall poor bacte-
rial load in these urine samples, our examination of voided urine
collected prior to bladder harvest revealed several long filaments
along with short rods (see Fig. S4b and c).
Variation in damX expression levels resulted in reversible
filamentation. In order to prove that transient DamX overpro-
duction is key to reversible UTI89 filamentation, we cloned the
UTI89 damX gene with a strong upstream Shine-Dalgarno se-
quence in pBAD33, to form pSKdamX, thereby allowing for
arabinose-induced expression and subsequent tight repression by
glucose addition. Previously, Lyngstadaas et al. (31) reported that
overproduction of DamX was detrimental to cell growth. Initial
attempts to induce damX overexpression during growth in liquid
medium proved more challenging than anticipated and did not
yield filaments. Unlike the earlier flow chamber experiments that
simulated bladder infection, examination of the effect of damX
overexpression from pSKdamX was performed by seeding UPEC
on an abiotic glass surface, for ease of handling. Strain UTI89/
pSKdamX was therefore cultured overnight on LB agar plates sup-
plemented with 0.4% glucose to ensure complete repression of
FIG 3 Strain UTI89damX in vivo infection reflects the failure to form filaments in vitro. Splayed urinary bladders of C3H/HeN mice were examined for IBCs
at 12 hpi in strains UTI89/pMAN01 (a) and UTI89damX/pMAN01 (b) and for filaments also at 18 hpi for strains UTI89/pMAN01 (c and d) and UTI89damX/
pMAN01 (e). White arrowheads in panel b denote IBCs. Urine collected from strain UTI89/pMAN01-infected bladders at 12 hpi, prior to organ harvest, was
examined and revealed sloughed epithelial cells with IBCs (f) as well as bacterial filaments (g). Urine examined after strain UTI89damX/pMAN01 infection,
12 hpi, also revealed sloughed epithelial cells with IBCs (h) but only rod-shaped bacteria (i). White arrowheads in panel “i” point to individual bacteria. Scale bars,
1 mm (a and b) and 10 m (c to i).
FIG 4 Enhanced clearance of strain UTI89damX infection from C3H/HeN
bladders. Bladders harvested from C3H/HeN mice infected with strain UTI89/
pMAN01 (circles) or strain UTI89damX/pMAN01 (squares) 18 hpi, 48 hpi,
and 14 days postinfeciton were homogenized, and suitable dilutions were
plated for CFU counts. The 100 data on the y axis of the graph are equivalent to
a finding of no detectable bacteria during CFU counting. Infections were car-
ried out in 5 mice per group in two independent rounds of experimentation. A
Mann-Whitney test was applied to calculate statistical significance, and the
P value was found to be0.05.
DamX Controls Reversible UPEC Filamentation
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damX expression from pSKdamX and seeded onto sterile glass
slides inserted into the flow chamber. After 20 min of seeding, the
chambers were exposed to a flow of EZ medium supplemented
with 0.2% arabinose. Microscopy images captured at 10-min in-
tervals clearly demonstrated the effect of damX overexpression on
UTI89 cell morphology (Fig. 5a to d). Since the morphological
plasticity observed during infection entails not only the ability to
form filaments but also the ability for those filaments to revert to
normal rod-shaped bacteria (25), it was important to demonstrate
that termination of damX overexpression with the subsequent ad-
dition of 0.4% glucose would facilitate UTI89 filament reversal.
This was indeed our observation (Fig. 5e and f). Strain UTI89/
pSKdamX exposed exclusively to EZ plus 0.4% glucose was ob-
served in parallel in order to clearly demonstrate that UTI89 fila-
mentation was indeed a result of damX overexpression. As seen in
Fig. 5g to l, this control experiment yielded a complete absence of
filaments. Concurrently, the vector control strain UTI89/pBAD33
was also tested in the presence of 0.2% arabinose and was found
not to form filaments (see Videos S1a to c in the supplemental
material).
In light of preexisting knowledge that damX overexpression
results in E. coli K-12 filamentation and that the pBAD system is
admittedly an artificial setup, a comparison of DamX levels be-
tween native UTI89 filaments flushed out of the flow chamber
model and artificial arabinose-induced UTI89/pSKdamX strain
filaments would be critical to validation of this experiment. By
Western blot analysis, the DamX level in arabinose-induced
UTI89/pSKdamX filaments was found to be elevated and compa-
rable to that of native UTI89 filaments obtained from a flow
chamber infection experiment (Fig. 6a). This was in contrast to
uninduced UTI89/pSKdamX and rod-shaped UTI89 cells result-
ing from filament reversal, which contained much lower DamX
levels.
Both array and real-time PCR data revealed elevated levels of
ftsZ expression in native UTI89 filaments. Based on prevailing
knowledge linking ftsZ overexpression to a filamentous pheno-
type, we then proceeded to determine FtsZ levels in these samples
by Western analysis. We found that FtsZ levels were elevated in the
native filaments (Fig. 6a, lane 4) compared to reverted filaments
(lane 5), as expected from our transcriptional data. Concurrently,
while we observed an increase in FtsZ levels in the arabinose-
induced filaments (lane 2) compared to the preinduction rods
(lane 1), there was no discernible drop in FtsZ levels in glucose-
induced reverted filaments (lane 3). This suggested that UTI89
filaments were not merely due to ftsZ overexpression and, second,
that damX overexpression was not directly linked to ftsZ overex-
pression. Microscopic examination was performed to confirm the
morphology of bacteria flushed out of the flow chambers from
each of the five samples used for Western blotting (Fig. 6b).
DISCUSSION
While the survival advantage conferred by morphological differ-
entiation on UPEC infection has been recognized (9, 12), the pre-
cise mechanisms underlying this phenomenon have not been re-
solved thus far. This study adopted a novel approach that allowed
for transcriptional profiling of distinct phases of UPEC infection
and thereby identified a relatively unexplored cell division pro-
tein, DamX, as critical to reversible UPEC filamentation.
The understanding of UPEC pathogenesis has grown consid-
erably since the earliest reports detailing the various stages of in-
fection observed in murine cystitis models (11, 25). UPEC has
been known to demonstrate a complex infection cycle in the blad-
der, commencing with adhesion and invasion of the superficial
bladder epithelial cells (24), within which the bacteria replicate to
form dense intracellular communities of coccoid bacteria, classi-
fied as IBCs. The model proposes that a subpopulation within
these IBCs then undergoes a process of maturation to form fila-
ments that undergo flux from the infected epithelial cell, and sub-
sequently reverts to normal rod-shaped bacteria that hold the po-
tential to reinitiate a fresh cycle of infection. This cyclic transition
between intra- and extracellular localization along with a concur-
rent transition between rod-shaped, coccoid, and filamentous cell
morphologies provides a mechanistic framework for explain-
ing the high degree of recurrences observed among infected
individuals (42). Observations from this and previous studies (9)
suggest that the filamentous phase of UPEC infection must be
FIG 5 Overexpression of damX induces reversible UTI89 filamentation. Time-lapse images of strain UTI89/pSKdamX seeded on glass slides subjected to a flow
of medium supplemented with 0.2% arabinose (white triangles) shown (a to d) or 0.4% glucose (white squares) (e and f), sequentially. (g to l) A negative control
in which strain UTI89/pSKdamX was only subjected to 0.4% glucose (white squares) mediated damX repression. Addition of 0.2% arabinose (white triangles)
allowed damX overexpression and filamentation therein, as seen in panels a to d. This filamentation phenotype was lost when damX induction was turned off,
as seen in panels e, f, and g to l. Images were collected at 20-min intervals. Scale bars, 20 m.
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transient and reversible in order to ensure progression of UTIs
from the primary episode. In this study, we observed that strain
UTI89damXwas incapable of forming filaments either in vitroor
in vivo. The mutant strain displayed no reduction in bladder cell
adhesion or invasion in vitro. Furthermore, the rate of strain
UTI89damX replication was comparable to that of the wild type
both when cultured in human urine and when residing intracel-
lularly in vivo. Indeed, we detected exfoliated cells containing late-
stage IBCs in mouse urine after infection by strain UTI89damX
(Fig. 3h). Collectively, our in vitro and in vivo infection data point
toward a function for DamX in the late stages of a primary infec-
tion cycle, i.e., when filament formation may be required for
maintenance and spread of the initial colonization.
While in the extracellular space, facing the combined threats of
elimination through bladder voiding (micturition) or phagocyto-
sis by polymorphonuclear leukocytes recruited to the bladder lu-
men surface at the point of infection, the adoption of a filamen-
tous morphology can be advantageous both in terms of tissue
adherence and immune evasion. Such morphological plasticity
has been known to offer selective advantages, such as host im-
mune evasion by UPEC (9, 12) and Proteus mirabilis (43), antibi-
otic resistance in Burkholderia pseudomallei (44), and stress resis-
tance in Caulobacter crescentus (45). By employing an in vitro flow
chamber infection model (22) with the ability to recapitulate
UPEC behavior reported during in vivo murine infection, UPEC
could be harvested from the three main phases of infection—
intracellular, filamentous, and reversal. Hence, this study further
emphasizes the utility of the flow chamber infection model as a
tool allowing for systematic analysis of bacterial gene expression in
the course of infection.
Bacterial cells elongate to form filaments when there is a failure
to complete cell division after segregation of nucleoids has oc-
curred. Our comparison of UTI89 transcriptional profiles during
the three infection phases revealed temporal expression of several
genes involved in cell division, indicating a change in the expres-
sion levels of cell division genes during filamentation compared to
intracellular and reversal phases, during which cell division would
be expected to occur more or less normally. Previous fluorescence
microscopic inspection of UPEC filaments generated in flow
chambers revealed segregated nucleoids and partial septa (22),
suggesting that the arrest in cell division occurred at a stage sub-
sequent to proto-ring formation by FtsZ, FtsA, and ZipA. We
hypothesize that the elevated expression of transcripts of other
divisome proteins (like ZapA, ZapB, ZapC, FtsX, FtsK, and FtsL)
observed in the array data, as well as the enrichment of the cell
division gene ontology (see Fig. S1b and S2 in the supplemental
material) could reflect filaments poised for initiation of cell divi-
sion as soon as the relevant environmental cue is perceived.
Justice et al. (9) previously suggested that SulA could underlie
the process of UPEC filamentation in an immunocompetent host
with the ability to mount a host immune response and thereby
incite a bacterial SOS response. Such evidence for SulA-mediated
filamentation has also been reported in other pathogens, like Lis-
teria monocytogenes (46) and Salmonella enterica serovar Typhi-
murium (47), under the onslaught of phagocytic immune cells. In
agreement with previous flow chamber model experiments (22),
we did not observe filamentation defects in strain UTI89sulA,
indicating that this gene is not responsible for the filamentation
observed during secondary surface colonization in vitro. Among
the candidate mutant strains tested using the flow chamber model
in this study, strain UTI89damX was the only one to display an
absence of filamentation as well as secondary surface colonization
of the bladder epithelial cells. However, these results do not rule
out that recruitment and interaction with neutrophils contributes
to the induction of UPEC filamentation in vivo. UPEC may there-
fore adopt more than one strategy to attain a filamentous mor-
phology, triggered by an SOS stress response during an immune
attack as well as a parallel DamX-mediated induction triggered by
FIG 6 The UTI89 morphological state is reflected in DamX protein levels. (a) Western blot analysis of DamX was performed. Lanes: 1, strain UTI89/pSKdamX
under 0.4% glucose repression prior to seeding on glass slides; 2, strain UTI89/pSKdamX filaments induced by 0.2% arabinose; 3, strain UTI89/pSKdamX
filament reversal under 0.4% glucose; 4, native UTI89 filaments; 5, reversed native filaments. Both of the upper bands correspond to DamX (34), the middle panel
corresponds to FtsZ levels, and the bottom panel shows GroEL expression, which was used as the internal loading control. (b) Microscopic examination of UTI89
strains from each of the respective samples from lanes 1 to 5 was performed to confirm morphological status. Scale bars, 20 m.
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the general physicochemical and hydrodynamic growth condi-
tions present in the bladder.
DamX is recruited to the midcell in an FtsZ-dependent manner
(33, 34) and interacts directly with septal peptidoglycan via its
C-terminal SPOR domain (36, 37). While deletion of damX was
found not to affect cell division in this or previous studies (33, 34),
overproduction of DamX has been linked to a filamentous phe-
notype in the past (31, 48). By using a bacterial two-hybrid screen,
DamX has been shown to interact strongly with itself, FtsQ, and
another SPOR domain-containing cell division protein, FtsN
(33). Z ring maturation and cell division have been described as
linear, dependent pathways, where perturbations in early proteins
influence assembly of later “downstream” proteins (49), and in
this context FtsN is believed to be the final recruit that links Z ring
maturation and septal peptidoglycan synthesis, as detailed in a
recent review by Weiss (50). Based on reported evidence that FtsN
and DamX both localize to the septal peptidoglycan by means of
their SPOR domains (34), it is tempting to speculate that DamX at
elevated levels could competitively inhibit FtsN self-accumulation
and block molecular interactions between essential cell division
proteins and/or septal peptidoglycan synthesis. However, findings
by Busiek and Margolin (51) demonstrated that FtsN was capable
of interacting with FtsA (an essential proto-ring component) in a
SPOR-independent manner, and since the FtsN and DamX SPOR
domains themselves show 20% identity conservation (35), the
mechanism of DamX-mediated filamentation might be more
complex than a mere case of competition. An alternative hypoth-
esis is that DamX sequesters FtsQ (33), a Z ring protein (15)
known to increase septal peptidoglycan turnover via FtsN-FtsA
interactions (52). The precise localization of Z ring components
during filament formation and reversal and the role that DamX
overproduction plays in this scheme remain subjects for future
study that we are currently pursuing.
The dam operon is comprised of seven functionally diverse
members, one of which is damX. Despite the positioning of alter-
native dam promoters within the damX coding region (40), dele-
tion of damX did not have any significant bearing on Dam meth-
ylase expression, thereby excluding the possibility that the lack of
filamentation observed for strain UTI89damX in flow chamber
infections was due to a polarity effect on Dam. Studies that have
associated deletion of damX with a reduced invasion capacity in
S. enterica (53) and induction of the SOS response in E. coli (54)
were conducted on damX mutants generated using transposon
insertion and therefore likely to have suffered dam polarity effects.
The facts that strain UTI89damX invaded bladder epithelial cells
as efficiently as the wild type but was defective with respect to both
secondary surface colonization and filament formation upon ex-
posure to concentrated urine in the flow chamber model suggest a
role for DamX in UPEC secondary infection. The exact mechanis-
tic role of DamX-mediated filamentation needs further clarifica-
tion; however, the defect in secondary surface colonization corre-
sponds with a role of filamentation in urothelial cell adherence
under hydrodynamic conditions, as suggested previously (9, 22).
Examination of filaments that were artificially induced from
the pSKdamX construct and those native filaments obtained dur-
ing the course of a flow chamber infection revealed comparable
DamX protein levels. DamX levels in filaments (both induced and
native) that had reverted to rod shape were also consistent among
themselves and significantly lower than their filamentous coun-
terparts. The effective corroboration of DamX levels with the cor-
responding morphological state in each of the UTI89 samples
tested further strengthens the postulation of DamX as a mediator
of UPEC morphological plasticity. Induction of UPEC filamenta-
tion via transient DamX overproduction from plasmid pSKdamX
occurred only when seeded on a solid surface, thus implying a role
for surface sensing and possibly fluid flow, irrespective of whether
that surface is biotic (bladder epithelial cells) or abiotic (glass).
This dependency of UPEC filamentation on surface growth has
been confirmed in other recent studies of UTI89 grown in flow
chambers (22, 23), implying that the process of filamentation does
not restrict itself exclusively to the UPEC infection cascade.
We compared the phenotypes resulting from damX overex-
pression in K-12, for which earlier studies had shown filament
formation in liquid culture, to UPEC, for which liquid culture
failed to result in filament formation even in concentrated urine.
Despite the high degree of sequence conservation between K-12
and UTI89, the prerequisite for a solid surface for filamentation
clearly applied only to UTI89 (see Fig. S5 in the supplemental
material). The reason for this difference is unknown, but it is
tempting to speculate that UPEC-specific surface fimbriae might
be implicated in controlling damX induction. Leclerc et al. (53)
reported the failure of osmolarity, pH, and oxygen tension as trig-
gers of damX overexpression in their study of S. enterica. Taken
together with the surface dependence of stable DamX-mediated
filaments observed in our study, upstream activators of damX ex-
pression and hence UPEC filamentation could be those involved
in surface sensing. However, such a mechanism might seem at
odds with the absence of UPEC filaments in bladders derived from
infected immunocompromised mice reported by Justice et al. (9).
Therefore, we cannot exclude a role of the host immune system in
the induction of DamX-mediated filaments.
The Cpx two-component system monitors biogenesis of bac-
terial surface structures and acts as a sensor of envelope stress, and
it has been shown to be important for UPEC virulence (55). Sur-
face structures such as fimbriae are crucial for attachment of
UPEC to bladder epithelia (56) as well as abiotic surfaces (57), and
UPEC filaments are known to express type 1 fimbriae on their
surface, allowing the cells to better adhere to a contact surface in
the face of a fluid shear force (22). In this context, it is likely that
the Cpx system is activated by the perception of a contact surface
by the bacterium (58). Also, in light of studies associating filament
formation with decreased antibiotic sensitivity, previous reports
of increased antibiotic sensitivity in cpx null mutants (55) might
point back to a lack of DamX-mediated filamentation in such
mutants.
We report here, for the first time, the involvement of DamX in
reversible UPEC filamentation, and we demonstrate a clear asso-
ciation between expression of damX and morphotype switching in
UTI89. Our study suggests an alternative explanation for the fila-
mentous response observed in the late and extracellular stages of
the IBC cycle. Our data point to DamX as a key inducer of fila-
mentation at this stage of the life cycle, triggered by the drastic
changes under growth conditions occurring in the transition from
intracellular proliferation to the urine- and liquid shear-exposed
surface growth on the bladder lumen. In addition, neutrophil at-
tack most likely contributes to induction of filamentation via an
SOS response, triggered by secreted reactive oxygen species (12).
The molecular mechanism of DamX-mediated cell division in-
hibition is presently unknown and, given the important clinical
Khandige et al.
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implications, further studies aimed at uncovering the DamX mor-
phological switch are warranted.
MATERIALS AND METHODS
Ethics statement. Mice used in this study were handled in accordance
with the current guidelines from the National Danish Animal Care Com-
mittee. Animal maintenance and experimental protocols were approved
by the Ministry of Food, Agriculture and Fisheries, Danish Veterinary and
Food Administration (ID 2015-15-0201-00480).
Bacterial strains and growth conditions. UTI89, a human cystitis
isolate of the O18:K1:H7 serotype (24), was used as the model uropatho-
genic E. coli strain in this study. Deletion strains were constructed in
UTI89 by the well-established lambda Red recombinase method devised
by Datsenko and Wanner (59) using pKD3 and pKD4 plasmids. Strain
UTI89damX was constructed using extended regions of complementa-
rity to damX 5= (JMJ553 and JMJ554) and 3= (JMJ555 and JMJ556) flank-
ing regions on the UTI89 chromosome. Strain UTI89damX* was con-
structed using the primers JMJ519 and JMJ991 and confirmed using
JMJ491 and JMJ998. All gene deletions were confirmed using gene-
specific primers.
Plasmid pSKdamX was derived from a pBAD33 plasmid vector by
insertion of a damX insert with the parM Shine-Dalgarno generated by
PCR using primers JMJ777 and JMJ600. The vector and insert were di-
gested using XbaI and HindIII fast digest restriction enzymes (Thermo
Scientific) and ligated with T4 DNA ligase (Roche), and the sequence was
verified. Plasmid pMAN01 was derived from pSC101 plasmid with a con-
stitutively active promoter driving gfp expression. Strains were main-
tained using 30 g/ml chloramphenicol (Cml) or 50 g/ml kanamycin
(Kan) as appropriate. All strains and primers are listed in Table S2 in the
supplemental material.
UTI89 was cultured at 37°C in Luria-Bertani medium, EZ medium
(catalog number m2105; Teknova) without glucose, or in human urine
with a USG ranging between 1.025 and 1.030, as suitable. Human urine
was filter sterilized, and the USG was measured as detailed previously by
Andersen et al. (22). All UTI89 strains were grown in LB medium statically
overnight for use in flow chamber and static infection experiments. UTI89
strains used in mouse infections were cultured over two rounds of static
growth in LB medium at 37°C as detailed previously (60). Induction and
repression of pSKdamX were carried out in EZ medium supplemented
with 0.2% arabinose and 0.4% glucose as appropriate.
Cell culture and infection experiments. In vitro infection experi-
ments were performed on PD07i, an immortalized human bladder epi-
thelial cell line kindly provided by David Klumpp (61). The cell line was
maintained in Epilife growth medium (Invitrogen) supplemented with
human keratinocyte growth serum (HKGS) and penicillin-streptomycin
(Pen/Strep) antibiotics during routine culturing at 5% CO2 and 37°C.
Epilife medium without Pen/Strep was utilized during infection. Static as
well as flow chamber-based infection experiments were carried out as
explained in detail previously (22). Briefly, urothelial monolayers cul-
tured for 24 h in tissue culture medium were infected for 20 min by
infusion of bacterial cells grown overnight and diluted to an optical den-
sity at 600 nm (OD600) of 0.2 into the flow chamber at a flow rate of
15 l/min. Surface colonization and urothelial invasion proceeded in a
peptone/glucose medium (antibiotic-free Epilife plus 1% HKGS with
0.5% peptone and 0.5% glucose) for ~9 h before removal of extracellular
bacteria by addition of 100 g/ml gentamicin to the medium for 20 h.
Bacterial filamentation and secondary surface colonization were induced
by shifting from the growth medium to concentrated urine (USG,
1.025) for 22 to 24 h. Secondary surface-colonizing bacteria were eluted
by detaching the pump and elevating the medium flask to increase hydro-
static pressure and manually tapping the inlet tubing to apply adequate
shearing force to release bacteria from the cell layers.
Mouse strain and infection. Eight-week-old female C3H/HeN mice
(Janvier Labs, France) were inoculated with 50 l of a culture with an
OD600 of 1 (~5 108 bacteria) by transurethral catheterization. Bladders
were harvested 18 h postinfection to be bisected, splayed on silicone pads,
and fixed in 3% paraformaldehyde solution for microscopy. Urine from
infected mice was collected immediately prior to tissue harvest and fixed
using 10% formalin buffer. Bladders for CFU counts were harvested 18 h,
48 h, and 14 days postinfeciton, homogenized, and suitably diluted (10,
102, 103, and 104) for CFU plating. Each UTI89 strain was tested on a
group of 5 mice, and the experiments were performed twice in their en-
tirety. Mouse infection and sample preparation were performed in strict
adherence to previously published protocols reported by Hung et al. (60).
DamX-induced filament formation. Induction of filamentation in
strain UTI89/pSKdamX was performed by resuspending bacteria grown
overnight on LB agar plates with 0.4% glucose and 30g/ml Cml in sterile
phosphate-buffered saline (PBS) to an OD600 of 0.1 and seeding on sterile
glass slides within flow chambers for 20 min at a flow rate of 100 l/min.
Flow chambers were subjected to a flow of EZ medium with 0.2% arabi-
nose and 30 g/ml Cml at 37°C at a constant flow rate of 50 l/min and
observed for filamentation. Reintroduction of 0.4% glucose to the EZ
medium was used to force reversal of filaments in the flow chambers.
Strains MG1655/pSKdamX and UTI89/pSKdamX were cultured on both
LA plates and LB broth in the presence of the inducer (0.2% arabinose) or
repressor (0.4% glucose) as appropriate, to ascertain phenotypic differ-
ences.
Microarray sample preparation. UTI89 was grown overnight at 37°C
in both LB medium and urine as reference conditions for analysis. Bacte-
ria were pelleted by centrifugation, washed with sterile PBS, and frozen in
liquid nitrogen. UTI89 was harvested from the flow chambers at the in-
tracellular phase by carefully dismantling the chambers to obtain the glass
slides with infected bladder cells. Lysing of the infected PD07i cells was
performed by pipetting 0.1% Triton X-100 (reconstituted in sterile PBS)
directly onto the glass slides that had been placed in a sterile petri dish, and
the lysate was collected in sterile Falcon tubes. Intracellular bacteria were
washed with sterile PBS, pelleted, and frozen in liquid nitrogen. Filaments
formed within the flow chambers were flushed out of the chambers and
frozen in liquid nitrogen after one wash with sterile PBS. For the filament
reversal phase, harvested filaments were maintained at 37°C in a 1:1 sus-
pension of antibiotic-free HKGS-supplemented Epilife medium and PBS
for 3 h in accordance with earlier studies (22). The reverted rod-shaped
bacteria were examined microscopically to ensure reversal, pelleted by
centrifugation, and frozen. Biological triplicates were used for each phase
of UTI89 infection. RNA isolation was performed using heavy phase-lock
gel tubes (5Prime), and total RNA was dissolved in RNase-free water.
RiboGuard (Epicenter) was used to inhibit RNA degradation. Subsequent
cDNA synthesis and Cy3 labeling were performed using the Low Input
Quick Amp labeling kit (Agilent Technologies) as per the manufacturer’s
recommendations.
Microarray design and analysis.Custom-designed 8-by-60,000 Sure-
Print G3 arrays from Agilent Technologies were used for microarray anal-
ysis. The arrays were designed to cover at least two independent probes
per gene as well as the intergenic regions of the UTI89 genome in four
replicates and 1,319 control probes for detection of hybridization effi-
ciency as well as eukaryotic control probes, using the eArray system (Agi-
lent Technologies). Hybridization was carried out using a gene expression
hybridization kit and wash buffers (Agilent Technologies) as per the man-
ufacturer’s recommendations and scanned using an Agilent scanner.
Feature-extracted files were analyzed using DNAStar software. Probe sig-
nal intensities were subjected to background correction, quantile normal-
ization, and median polish. To identify differentially expressed tran-
scripts, the log2 fold change was calculated (cutoff,2 log2 fold change),
and filtering was based on Student’s t test (significance cutoff, P 0.05).
The statistically significant, differentially expressed transcripts were fur-
ther examined based on gene ontology information obtained from Eco-
Cyc and literature searches.
Real-time PCR. Primers for real-time PCR, listed in Table S2c in the
supplemental material, were designed using Primer3 software. Total RNA
was isolated from each infection phase following the same protocol as for
DamX Controls Reversible UPEC Filamentation
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microarray sample preparation. Total RNA from UTI89 (wild type) and
strain UTI89damX (see Fig. S3a in the supplemental material) was har-
vested from exponentially growing bacteria in culture. One microgram of
total RNA was DNase treated for 30 min at 37°C and heat inactivated, then
used for cDNA synthesis using a Maxima first-strand cDNA synthesis kit
(Thermo Scientific). Real-time quantification was performed using SYBR
Select master mix (Life Technologies) as per the recommended protocol.
Levels of rrsA were used as an internal control, and real-time PCRs were
run in 96-well plates in an Mx3005P QPCR system (Agilent Technolo-
gies).
Flow cytometry. Flow cytometry was performed on a BD FACSAria II
flow cytometer (Becton, Dickinson and Company). UTI89 cells grown to
exponential phase as normal rod-shaped bacteria and filamentous UTI89
obtained from an in vitro flow chamber infection were fixed in 3.7%
paraformaldehyde prior to flow cytometry. Data from 105 events per sam-
ple were collected and analyzed using BD FACSDiva software (Becton,
Dickinson and Company). UTI89 from the two conditions was distin-
guished on the basis of FSC-A and SSC-A on the x and y axes, respectively.
Gating was performed using normal rod-shaped bacteria, such that all
bacterial events occurring outside gate P1 were designated “not P1” and
corresponded to cells longer than normal rod-shaped bacteria.
Microscopy. Each individual phase of UTI89 infection was confirmed
by microscopic inspection. All phase-contrast microscopy using UTI89
deletion strains during flow chamber infection was performed using a
Leica DMRE fluorescence microscope. Time-lapse imaging of filament
induction as well as mouse bladder and urine imaging were performed
with the Olympus cellSens Dimension platform v. 1.7 where, using a 40
objective, composite images obtained by collapsing 26 Z-stack slices with
a step size of 0.5 m were captured at 10-min intervals. Contrast adjust-
ment and scale bars were added using ImageJ software.
Western blotting. UTI89 filaments and strain UTI89/pSKdamX sam-
ples were obtained by flushing bacteria out of the flow chamber system
and snap-freezing. The bacterial cell pellets were resuspended in 1 SDS
loading buffer (60 mm Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 0.005%
bromophenol blue, 5 mm EDTA, 0.1 M dithiothreitol) and boiled for
5 min at 90°C with vigorous agitation. Protein from ~108 cells was loaded
and separated on 4-to-12% Invitrogen NuPage Novex bis-Tris minigels as
detailed by Boysen et al. (62). The proteins were transferred onto polyvi-
nylidene difluoride membranes (Amersham Hybond) that were probed
with a 1:1,000 dilution of anti-FtsZ (AgriSera), 1:1,000 dilution of anti-
DamX (35), or 1:10,000 anti-GroEL antibodies, followed by appropriate
secondary antibodies. Band quantification was performed using Image
Studio Lite v4 software.
Plasmid stability assay. Strains UTI89/pKD46 and UTI89damX/
pKD46 were grown overnight with aeration at 30°C in LB plus 100g/ml
Amp and used to subculture a starter culture in fresh LB plus 100 g/ml
Amp at 30°C to an OD600 of 0.3. The starter culture was diluted to an
OD600 of 0.03 in LB at 37°C and sampled every 30 min for CFU plating on
LB agar (LA) and LA plus 100 g/ml Amp plates. Cultures at 30°C in LB
plus 100 g/ml Amp were also used in a flow chamber-based infection of
PD07i bladder epithelial cells. Flow chamber-based infection was carried
out as before, without any Amp selection. A 100-g/ml concentration of
gentamicin was added 9 hpi, and the infection experiment was terminated
after 24 hpi. The chambers were subjected to three short 5-min bursts at a
higher flow rate (50 l/min) to wash away extracellular bacteria and sub-
sequently dismantled to obtain the glass slide with infected bladder cells.
The infected epithelial cells were trypsinized and lysed with 0.1% Triton.
Intracellular bacteria from infected bladder cells were harvested for CFU
plating on LA and LA plus 100 g/ml Amp plates. CFU counts from LA
and LA plus 100 g/ml Amp plates were used to calculate percentages of
plasmid retention over time {100 [(CFU with LA plus Amp)/(CFU with
LA)]}.
Statistical analysis. All infection and real-time reverse transcription-
PCR experiments were conducted on biological triplicates, and mean val-
ues were plotted along with standard deviations. Student’s t test was used
to calculate P values and determine statistical significance in stationary
infections by using GraphPad Prism 5.01 software. A Mann-Whitney un-
paired test was used to calculate the significance of mouse CFU counts
using GraphPad Prism 5.01 software. P values less than 0.05 were defined
significant for all experiments.
Microarray data accession number. Array data have been deposited
in ArrayExpress (accession number E-MTAB-3611).
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